Metabolic health for mothers · Reader-supported · 2026
Compare providers on price, clinical care and the questions that matter for pregnancy, nursing, PCOS and perimenopause. CoreAge Rx is a featured partner; providers we work with may appear first.
The ranking · 6 of 349 scored
CoreAge Rx is a featured partner; providers we work with may appear first. Commissions don't change scores. Scoring and funding.
CoreAge's officially linked public offer advertises compounded semaglutide at $79/month and tirzepatide at $129/month across doses, with care and overnight shipping included. It describes one-time purchases without a required subscription. Main navigation still shows semaglutide from $99; confirm your prescription quantity and total, and read the refund limits before paying.
Semaglutide from $129 and tirzepatide from $179 a month, all doses included — a reasonable option if you can live with a yearly plan, a month-to-month price you only see at checkout, and a pharmacy it doesn't name.
A compounded program that advertises ongoing provider care, metabolic testing every six months and shipping within its price. Semaglutide is $249 and tirzepatide $329 every four weeks without a longer commitment; lower equivalents require 12-, 24- or 48-week terms. Microdose and combination options need separate current quotes.
A real telehealth marketplace with a video visit and a clinician you pick — now brand-first, so you get on-label Wegovy or Zepbound with the manufacturer's own pregnancy labeling, if you can absorb a membership fee stacked on the drug price.
Physician-founded and genuinely cheap, with both molecules in a lozenge or a shot and a free MD visit — but a February 2026 FDA misbranding letter is a caveat a mother should read before signing up.
Prices and states reflect each provider's public pages at last review; the Metabolic-Fit Score is our editorial judgment. Prices change — confirm on the provider's site. Not medical advice.
Ranked boards
Start here
What the Wegovy and Zepbound labels actually say about nursing — and why the honest answer is about timing, not a flat yes or no.
Read the guide →A gestational-diabetes pregnancy raises long-term type-2 risk. Where GLP-1 care fits once you're past pregnancy and breastfeeding.
Read the guide →The midlife shift in body composition is measurable and real. How GLP-1 treatment fits alongside the hormonal changes of the transition.
Read the guide →More women's-health guides
Before you start
A quick, private self-check written for mothers. Nothing is saved or sent — it simply helps you decide whether to raise GLP-1 care with a clinician, and flags the pregnancy and breastfeeding timing questions first.
A private self-check
Reflective only — not a diagnosis. Nothing is saved or sent.
0 of 6 selected. Tick the ones that sound like you — there are no wrong answers.
Six factors weighted for mothers — postpartum and breastfeeding guidance, PCOS and hormonal fit, clinical oversight and labs — each with a published weight.
Most telehealth brands aren't OB or hormone clinics. We say where the postpartum or PCOS framing is general, and score it accordingly.
Affiliate status is disclosed site-wide. CoreAge Rx is a featured partner; providers we work with may appear first. Commissions don't change a provider's score.
Featured partner
CoreAge Rx scores 86/100 on the Metabolic-Fit Score: flat pricing, a clinician who will talk through timing, and both molecules subject to therapy and state eligibility. Read the full review, or start an intake — you can weigh it against the rest first.